BIO EBITDA Growth
Bio-Rad Laboratories, Inc. Class A Common Stock · EBITDA Growth
BIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.72%period ending
BIO TTM EBITDA YoY % (31.37% → -22.72%)
Year-over-year change
High-resolution chart · PNG
BIO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.717% | |
| 117.323% | |
| 156.753% | |
| 22.9649% | |
| 143.4606% | |
| -927.5474% | |
| -225.5928% | |
| -7,970.7427% | |
| -353.4989% | |
| -304.9829% | |
| 85.528% | |
| 100.1336% | |
| 86.2281% | |
| 30.1837% | |
| -181.1763% | |
| -188.2072% | |
| -145.739% | |
| -101.6005% | |
| 9.9831% | |
| 86.7513% | |
| 103.4131% | |
| 152.8399% | |
| 112.2468% | |
| 586.6693% | |
| 93.16% | |
| 130.4375% | |
| 253.8643% | |
| -61.4917% | |
| -5.8313% | |
| -15.8437% | |
| 151.159% | |
| 815.1059% | |
| 707.6429% | |
| 442.0675% | |
| 30.1571% | |
| -33.8213% | |
| -37.8415% | |
| -30.4185% | |
| -31.9141% | |
| -2.9336% | |
| -5.5524% | |
| -7.7347% | |
| -2.2088% | |
| -4.2882% | |
| -0.9607% | |
| 2.0081% | |
| -4.3784% | |
| -7.144% | |
| -16.4319% | |
| -18.2915% | |
| -20.1615% | |
| -19.4207% | |
| -11.5746% | |
| -5.7293% | |
| -0.938% | |
| 5.1632% | |
| 4.9895% | |
| 3.2963% | |
| 4.326% | |
| 16.0918% | |
| 18.4474% | |
| 21.1933% | |
| 28.0393% | |
| 19.1916% | |
| 23.8338% | |
| 21.7019% | |
| 13.7421% | |
| 0.0425% | |
| 2.8851% | |
| 14.8117% | |
| 28.378% | |
| 43.4467% | |
| 37.3752% | |
| 17.2823% | |
| 2.2071% | |
| 0.6446% | |
| -1.6745% | |
| 9.4376% | |
| 16.627% | |
| 8.7223% | |
| 6.6289% | |
| -2.7698% | |
| -1.1627% | |
| 2.9841% | |
| 0.4394% | |
| 2.0978% | |
| -5.9691% | |
| -6.0211% | |
| -4.2966% | |
| -1.3727% | |
| 8.1167% | |
| 7.1543% | |
| 17.7066% | |
| 18.0282% | |
| 7.2274% | |
| 22.2943% | |
| 16.1714% | |
| 18.965% | |
| 35.494% | |
| 22.1484% |